U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 OUTPATIENT TREATMENT WITH ANTI-CORONAVIRUS IMMUNOGLOBULIN (OTAC)

A research study testing an experimental COVID-19 treatment called anti-coronavirus hyperimmune intravenous immunoglobulin (hIVIG).

WHAT IS THIS STUDY ABOUT?

The Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) study is testing hIVIG as a treatment for COVID-19 (SARS-CoV-2).

What is hIVIG? hIVIG stands for “hyperimmune intravenous immunoglobulin.” hIVIG is made from blood plasma donated by healthy people who have recovered from COVID-19. Plasma is the liquid part of your blood.

The plasma is collected and purified to make hIVIG. It contains high levels of antibodies that fight the virus that causes COVID-19. Antibodies are natural proteins made by the body to fight or prevent infection.

See how hIVIG Production and Administration works.

The OTAC study is testing hIVIG to answer the following questions:

  • Can this drug help people have fewer COVID-19 symptoms?
  • Can the drug help people with COVID-19 stay out of the hospital?
  • Is this drug safe for people with COVID-19 who may have a higher risk of getting very sick from their infection?

If you join this study, you will receive one dose of hIVIG or a placebo (that is, one and a quarter cups of salt water which has no drug in it). Your chance of receiving the study drug will be 50%, which is just like flipping a coin. You will get the drug or placebo as a drip through a small plastic tube that is put into a vein in your arm. The study team will watch you while the dose is being given. They will also watch you after the dose is given. You will get the usual standard care for COVID-19 that you would receive even if you were not in a study. Your decision to join the study is purely up to you, and you can change your mind at any time.

Image
Schedule of OTAC study participation activities, including checking in six times over 28 days.

Your participation in this study will last for 28 days. You will check your temperature and your oxygen levels at home. Your study team will give you easy-to-use equipment at no cost to you to do this. Your study team will check on your health the day after the dose and then four more times after that. Most of the health checks can be done over the phone.


WHO CAN JOIN THIS STUDY?

If you recently tested positive for COVID-19, this study may be for you. Clinical trials testing investigational COVID-19 treatments need people from diverse backgrounds. This will help researchers find treatments that work for more people. Each person who takes part in the OTAC study will meet specific conditions, including:

Image
ID card icon
Age

At least 55 years old OR at least 18 years old with a weakened immune system or on medication that suppresses the immune system

Image
thermometer icon
COVID-19 Status

Not currently in the hospital, tested positive for COVID-19 within the past 5 days 

Image
symptoms icon
Symptoms

No symptoms OR COVID-19 symptoms for no longer than 5 days

There are other requirements that the study team will explain to you. If you do not meet the requirements, or if there is not a study site near you, there may be other COVID-19 studies that you can participate in.

HOW CAN I JOIN THIS STUDY?

If you are interested in joining the OTAC clinical trial or you would like more information:

Image
masked woman checking her temperature

RESOURCES

Image
Illustration of healthcare professional and patient
OTAC POWERPOINT PRESENTATION
Image
hIVIG Production and Administration cover image
hIVIG PRODUCTION AND ADMINISTRATION

OTAC TRIAL LOCATIONS

Find an OTAC trial site near you:

Show locations


ANSWERS TO OTHER QUESTIONS YOU MIGHT HAVE

Image
older man with a mask looking out of a window

A clinical research study helps patients and their healthcare providers find treatments that may be safe and effective. It is important that these studies include people from diverse backgrounds to represent all potential patients. This helps researchers develop new treatments that will work for everyone.

The placebo looks like the study medication but does not have any active ingredients in it. Researchers compare how people react to both placebos and medications to learn if the medication is safe and helps people recovery more quickly. If you join this study, you will get the usual care for COVID-19.

Yes. Taking part in this clinical trial is voluntary; it is your choice. You can change your mind at any time and leave the study.